• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用机器学习模型预测老年女性在接受阿霉素A治疗严重膀胱过度活动症后高残余尿量的预测因素。

Predictive Factors for High Post-void Residual Volume in Older Females After OnabotulinumA Treatment for Severe Overactive Bladder Using a Machine Learning Model.

作者信息

Okui Nobuo, Ikegami Tadashi, Hashimoto Tatsuo, Kouno Yuko, Nakano Kaori, Okui Machiko Aurora

机构信息

Dentistry, Kanagawa Dental University, Kanagawa, JPN.

Diagnostic Imaging, Kanagawa Dental University, Kanagawa, JPN.

出版信息

Cureus. 2023 Jul 29;15(7):e42668. doi: 10.7759/cureus.42668. eCollection 2023 Jul.

DOI:10.7759/cureus.42668
PMID:37525863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10387135/
Abstract

Introduction Intravesical onabotulinumA injection is actively used for the treatment of overactive bladder (OAB). However, it occasionally results in significant post-void residual urine (PVR) volume, which can lead to complications and can further impair the activities of daily living in older people. Therefore, this study aimed to identify the predictors of a high post-onabotulinumA injection PVR volume in older women with severe OAB. Methods An observational study was conducted on older women who had previously received intravesical onabotulinumA injections to treat OAB between 2020 and 2022. Urodynamic studies and symptom assessments were conducted, and machine learning models, including random forest and support vector machine (SVM) models, were developed using the R code generated by Chat Generative Pre-trained Transformer 4 (ChatGPT, OpenAI, San Francisco, USA). Results Among 128 patients with OAB, 23 (18.0%) had a PVR volume of > 200 mL after receiving onabotulinumA injections. The factors associated with a PVR volume of > 200 mL were investigated using univariate and multivariate analyses. Age, frailty, OAB-wet, daytime frequency, and nocturia were significant predictors. Random forest analysis highlighted daytime frequency, frailty, and voiding efficiency as important factors. An SVM model incorporating daytime frequency, frailty, and voiding efficiency improved PVR volume prediction. Logit(p) estimation yielded an area under the receiver operating characteristic curve of 0.926294.  Conclusion The study found daytime frequency, frailty, and voiding inefficiency to be significant factors associated with a PVR volume of > 200 mL, in older women with severe OAB. Utilizing advanced machine learning techniques and following the guidance of ChatGPT, this research emphasizes the relevance of considering multiple intersecting factors for predicting PVR volume. The findings contribute to our understanding of onabotulinumA injection treatment for OAB and support evidence-based decision-making using readily available information.

摘要

引言 膀胱内注射A型肉毒毒素积极用于治疗膀胱过度活动症(OAB)。然而,它偶尔会导致显著的排尿后残余尿量(PVR),这可能会引发并发症,并进一步损害老年人的日常生活活动能力。因此,本研究旨在确定重度OAB老年女性注射A型肉毒毒素后高PVR量的预测因素。方法 对2020年至2022年间曾接受膀胱内注射A型肉毒毒素治疗OAB的老年女性进行了一项观察性研究。进行了尿动力学研究和症状评估,并使用由Chat生成预训练变换器4(ChatGPT,OpenAI,美国旧金山)生成的R代码开发了包括随机森林和支持向量机(SVM)模型在内的机器学习模型。结果 在128例OAB患者中,23例(18.0%)在接受A型肉毒毒素注射后PVR量>200 mL。使用单变量和多变量分析研究了与PVR量>200 mL相关的因素。年龄、虚弱、OAB-湿型、白天排尿次数和夜尿症是显著的预测因素。随机森林分析强调白天排尿次数、虚弱和排尿效率是重要因素。纳入白天排尿次数、虚弱和排尿效率的SVM模型改善了PVR量预测。Logit(p)估计得出受试者工作特征曲线下面积为0.926294。结论 该研究发现,在重度OAB老年女性中,白天排尿次数、虚弱和排尿效率低下是与PVR量>200 mL相关的显著因素。利用先进的机器学习技术并遵循ChatGPT的指导,本研究强调了考虑多个交叉因素以预测PVR量的相关性。这些发现有助于我们理解A型肉毒毒素注射治疗OAB,并支持使用现有信息进行循证决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a1/10387135/e9162c870dc6/cureus-0015-00000042668-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a1/10387135/9f21d2c1cb5c/cureus-0015-00000042668-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a1/10387135/e9162c870dc6/cureus-0015-00000042668-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a1/10387135/9f21d2c1cb5c/cureus-0015-00000042668-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a1/10387135/e9162c870dc6/cureus-0015-00000042668-i02.jpg

相似文献

1
Predictive Factors for High Post-void Residual Volume in Older Females After OnabotulinumA Treatment for Severe Overactive Bladder Using a Machine Learning Model.使用机器学习模型预测老年女性在接受阿霉素A治疗严重膀胱过度活动症后高残余尿量的预测因素。
Cureus. 2023 Jul 29;15(7):e42668. doi: 10.7759/cureus.42668. eCollection 2023 Jul.
2
Urodynamic prognostic factors for large post-void residual urine volume after intravesical injection of onabotulinumtoxinA for overactive bladder.经膀胱内注射肉毒毒素 A 治疗膀胱过度活动症后排尿后残余尿量较大的尿动力学预测因素。
Sci Rep. 2017 Mar 6;7:43753. doi: 10.1038/srep43753.
3
A Discrete Mathematics Approach for Understanding Risk Factors in Overactive Bladder Treatment.一种用于理解膀胱过度活动症治疗中风险因素的离散数学方法。
Cureus. 2024 Jan 30;16(1):e53245. doi: 10.7759/cureus.53245. eCollection 2024 Jan.
4
Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine.有膀胱过度活动症症状的老年女性的排尿功能障碍:残余尿量正常和升高的女性之间尿动力学参数的比较
Neurourol Urodyn. 2016 Jan;35(1):95-9. doi: 10.1002/nau.22689. Epub 2014 Nov 14.
5
Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.膀胱内注射A型肉毒杆菌毒素治疗膀胱过度活动症的疗效相关因素
PLoS One. 2016 Jan 29;11(1):e0147137. doi: 10.1371/journal.pone.0147137. eCollection 2016.
6
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?膀胱内注射A型肉毒杆菌毒素治疗膀胱过度活动症和间质性膀胱炎患者的不良事件——肉毒杆菌毒素对膀胱功能障碍的不同作用机制?
Toxins (Basel). 2016 Mar 16;8(3):75. doi: 10.3390/toxins8030075.
7
Urinary retention in female OAB after intravesical Botox injection: who is really at risk?膀胱内注射肉毒杆菌毒素后女性膀胱过度活动症患者的尿潴留:真正的风险人群是谁?
Int Urogynecol J. 2017 Jun;28(6):845-850. doi: 10.1007/s00192-016-3212-4. Epub 2016 Nov 26.
8
What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?对于同时存在储尿期和排尿期症状的患者,α1受体阻滞剂治疗后膀胱过度活动症症状改善的影响因素有哪些?
Urol Int. 2019;103(4):439-443. doi: 10.1159/000502661. Epub 2019 Sep 25.
9
Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome-A real-life practice of 290 cases in a single center.膀胱内注射皮下注射A型肉毒毒素治疗膀胱过度活动症后不良事件的预测因素——单中心290例真实病例分析
Neurourol Urodyn. 2017 Jan;36(1):142-147. doi: 10.1002/nau.22892. Epub 2015 Sep 28.
10
Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study.膀胱内注射A型肉毒杆菌毒素治疗小儿非神经源性膀胱过度活动症的疗效与安全性:一项前瞻性病例系列研究。
Arab J Urol. 2019 Apr 24;17(2):143-149. doi: 10.1080/2090598X.2019.1600993. eCollection 2019.

引用本文的文献

1
Association and Prevalence of Lower Urinary Tract Symptoms in Individuals with Sarcopenia: A Systematic Review and Meta-Analysis.肌少症患者下尿路症状的相关性及患病率:一项系统评价和荟萃分析。
Medicina (Kaunas). 2025 Jul 3;61(7):1214. doi: 10.3390/medicina61071214.
2
Frailty and the Correlation Between Total Testosterone Levels and Urinary Incontinence Among Elderly Women.虚弱与老年女性总睾酮水平和尿失禁的相关性。
Int Urogynecol J. 2024 Sep;35(9):1909-1919. doi: 10.1007/s00192-024-05906-0. Epub 2024 Aug 31.
3
A Discrete Mathematics Approach for Understanding Risk Factors in Overactive Bladder Treatment.

本文引用的文献

1
Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.人参养荣汤改善虚弱患者的泌尿生殖系统症状。
Cureus. 2023 Jun 21;15(6):e40767. doi: 10.7759/cureus.40767. eCollection 2023 Jun.
2
Potentially inappropriate medication use is associated with increased risk of incident disability in healthy older adults.潜在不适当药物使用与健康老年人发生残疾的风险增加有关。
J Am Geriatr Soc. 2023 Aug;71(8):2495-2505. doi: 10.1111/jgs.18353. Epub 2023 Apr 11.
3
Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder-Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes.
一种用于理解膀胱过度活动症治疗中风险因素的离散数学方法。
Cureus. 2024 Jan 30;16(1):e53245. doi: 10.7759/cureus.53245. eCollection 2024 Jan.
A型肉毒毒素膀胱内注射治疗难治性膀胱过度活动症-年轻和老年人群的结果比较,以及与不良结局相关的因素。
Toxins (Basel). 2023 Jan 19;15(2):95. doi: 10.3390/toxins15020095.
4
Unraveling the impact of spp. and other urinary microorganisms on the efficacy of mirabegron in female patients with overactive bladder.探讨 spp. 和其他尿路微生物对米拉贝隆治疗女性膀胱过度活动症疗效的影响。
Front Cell Infect Microbiol. 2022 Nov 14;12:1030315. doi: 10.3389/fcimb.2022.1030315. eCollection 2022.
5
Botulinum toxin A injection to the external urethral sphincter for voiding dysfunction in females: A tertiary center experience.肉毒毒素 A 注射至女性尿道外括约肌治疗排尿功能障碍:一家三级中心的经验。
Neurourol Urodyn. 2022 Nov;41(8):1793-1799. doi: 10.1002/nau.25023. Epub 2022 Aug 18.
6
Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatment.患者对膀胱状况感知评分与基线和治疗后膀胱过度活动症症状之间的关联。
Neurourol Urodyn. 2022 Aug;41(6):1399-1405. doi: 10.1002/nau.24960. Epub 2022 May 20.
7
A non-interventional cross-sectional re-contact study investigating the relationship between overactive bladder and frailty in older adults in Japan.一项在日本进行的非介入性、横断面再联系研究,旨在调查老年人群中膀胱过度活动症与虚弱之间的关系。
BMC Geriatr. 2022 Jan 21;22(1):68. doi: 10.1186/s12877-022-02756-7.
8
Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network.在治疗膀胱过度活动症的肉毒毒素注射后出现不完全排空膀胱和尿路感染:来自 SUFU 研究网络的多机构合作。
Neurourol Urodyn. 2022 Feb;41(2):662-671. doi: 10.1002/nau.24871. Epub 2022 Jan 12.
9
Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis.肌少症预测老年冠心病患者不良结局:系统评价和荟萃分析。
BMC Geriatr. 2021 Sep 14;21(1):493. doi: 10.1186/s12877-021-02438-w.
10
Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial.在一项随机对照试验中,基于性别和男性血清前列腺特异性抗原水平的亚组分析,观察到昂丹司琼在膀胱过度活动症患者中的疗效和安全性。
Int Urol Nephrol. 2021 Nov;53(11):2243-2250. doi: 10.1007/s11255-021-02962-z. Epub 2021 Jul 22.